-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enzalutamide in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enzalutamide in Peritoneal Cancer Drug Details: Enzalutamide (Xtandi) is a phenylimidazolidine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enzalutamide in Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enzalutamide in Adenocarcinoma Drug Details: Enzalutamide (Xtandi) is a phenylimidazolidine derivative, acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enzalutamide in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enzalutamide in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enzalutamide in Endometrial Cancer Drug Details: Enzalutamide (Xtandi) is a phenylimidazolidine...
-
Thematic Analysis
NewClean Label in Consumer Goods – Thematic Intelligence
Clean Label in Consumer Goods Thematic Report Overview The clean label theme is part of the broader health and wellness movement. It is crucial because a greater number of consumers in both mature and emerging economies are becoming increasingly conscious about leading healthier lifestyles and the impact of what they are consuming. Developments in AI are unlocking new possibilities in ingredient discovery. From a clean label point of view, AI's maturing utility in ingredient discovery could enable consumer goods companies...
-
Company Insights
MobilePay – Competitor Profile
MobilePay is a popular mobile payment solution in Denmark. Launched as a money transfer app by Danske Bank in 2013, it later extended its offering to include online, in-app, and in-store payments. It allows users to make fund transfers between friends, family members, and businesses using their phone number. Users can store card details within the MobilePay app, which can be used for payments at online and offline merchants. To make online payments, users choose MobilePay at the checkout and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (hyaluronidase (recombinant, Human) + Immune Globulin (human)) in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (hyaluronidase (recombinant, Human) + Immune Globulin (human)) in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (hyaluronidase (recombinant, Human) + Immune Globulin...
-
Sector Analysis
Slovakia Statutory and Private Employee Benefits, 2024 Update
Slovakia Statutory and Private Employee Benefits Overview Following independence in 1993, the Slovak government reformed taxation, healthcare, pensions, and the social welfare system. These reforms helped the government to consolidate the budget and move towards joining the EU in 2004. The country also introduced several investor-friendly policies – including labor market liberalization. The Slovakia employee benefits report provides in-depth industry analysis, information, and insights into employee benefits in Slovakia, including an overview of the state and compulsory benefits, detailed information...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ceclazepide in Helicobacter pylori Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ceclazepide in Helicobacter pylori Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ceclazepide in Helicobacter pylori Infections Drug Details: Ceclazepide (TR-2A) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Iloperidone in Bipolar I Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Iloperidone in Bipolar I Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Iloperidone in Bipolar I Disorder Drug Details: Iloperidone (Fanapt/ Fanaptum) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cenegermin in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenegermin in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cenegermin in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: Cenegermin (Oxervate)...